1-5 of 5
Keywords: Pembrolizumab
Close
Sort by
Journal Articles
Case Rep Dermatol (2024) 16 (1): 116–122.
Published Online: 17 May 2024
... acuta (PLEVA) that developed during pembrolizumab treatment for invasive bladder cancer. A 53-year-old man, receiving pembrolizumab for invasive bladder cancer, developed erythematous papules on his legs after his 11th infusion. The skin lesions gradually spread to his entire trunk and extremities...
Journal Articles
Journal Articles
Case Rep Dermatol (2021) 13 (3): 487–491.
Published Online: 08 October 2021
... with pemetrexed, carboplatin, and pembrolizumab, followed by 2 cycles of pembrolizumab monotherapy. On physical examination, violaceous scaly erythema grouped on his scalp and upper extremities. Histologically, the scalp lesions demonstrated irregular acanthosis that formed a characteristic saw-tooth appearance...
Journal Articles
Case Rep Dermatol (2018) 10 (2): 154–157.
Published Online: 05 June 2018
...Kenneth Thomsen; Jon Diernaes; Trine Heide Øllegaard; Eva Spaun; Christian Vestergaard Checkpoint inhibitors are novel and promising treatment options for different types of cancer. Programmed cell death 1 (PD-1) inhibitors, such as pembrolizumab, have been shown to significantly raise the survival...
Journal Articles
Case Rep Dermatol (2017) 9 (1): 65–68.
Published Online: 09 March 2017
... methotrexate was stopped. One week after initiation of ipilimumab, the patient developed typical symptoms of RA. Analgetic therapy was started. After 4 cycles of ipilimumab, melanoma progression was radiologically evident. The treatment plan was changed to pembrolizumab (anti-PD1 antibody), and the patient did...